![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine
Publisher: Spandidos Publications
ISSN: 1019-6439
Source: International Journal of Oncology, Vol.44, Iss.3, 2014-01, pp. : 959-969
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)